135 related articles for article (PubMed ID: 28685785)
1. Identification of human flap endonuclease 1 (FEN1) inhibitors using a machine learning based consensus virtual screening.
Deshmukh AL; Chandra S; Singh DK; Siddiqi MI; Banerjee D
Mol Biosyst; 2017 Jul; 13(8):1630-1639. PubMed ID: 28685785
[TBL] [Abstract][Full Text] [Related]
2. Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.
He L; Zhang Y; Sun H; Jiang F; Yang H; Wu H; Zhou T; Hu S; Kathera CS; Wang X; Chen H; Li H; Shen B; Zhu Y; Guo Z
EBioMedicine; 2016 Dec; 14():32-43. PubMed ID: 27852524
[TBL] [Abstract][Full Text] [Related]
3. Development of a high-throughput fluorescence polarization DNA cleavage assay for the identification of FEN1 inhibitors.
McWhirter C; Tonge M; Plant H; Hardern I; Nissink W; Durant ST
J Biomol Screen; 2013 Jun; 18(5):567-75. PubMed ID: 23427045
[TBL] [Abstract][Full Text] [Related]
4. Small molecule inhibitors uncover synthetic genetic interactions of human flap endonuclease 1 (FEN1) with DNA damage response genes.
Ward TA; McHugh PJ; Durant ST
PLoS One; 2017; 12(6):e0179278. PubMed ID: 28628639
[TBL] [Abstract][Full Text] [Related]
5. FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer.
He L; Luo L; Zhu H; Yang H; Zhang Y; Wu H; Sun H; Jiang F; Kathera CS; Liu L; Zhuang Z; Chen H; Pan F; Hu Z; Zhang J; Guo Z
Mol Oncol; 2017 Jun; 11(6):640-654. PubMed ID: 28371273
[TBL] [Abstract][Full Text] [Related]
6. The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors.
Tumey LN; Bom D; Huck B; Gleason E; Wang J; Silver D; Brunden K; Boozer S; Rundlett S; Sherf B; Murphy S; Dent T; Leventhal C; Bailey A; Harrington J; Bennani YL
Bioorg Med Chem Lett; 2005 Jan; 15(2):277-81. PubMed ID: 15603939
[TBL] [Abstract][Full Text] [Related]
7. Investigation of human flap structure-specific endonuclease 1 (FEN1) activity on primer-template models and exploration of a substrate-based FEN1 inhibitor.
Ba S; Zhang H; Lee JY; Wu H; Ye R; Huang D; Li T
Bioorg Med Chem; 2016 May; 24(9):1988-92. PubMed ID: 27020684
[TBL] [Abstract][Full Text] [Related]
8. FEN1 endonuclease as a therapeutic target for human cancers with defects in homologous recombination.
Guo E; Ishii Y; Mueller J; Srivatsan A; Gahman T; Putnam CD; Wang JYJ; Kolodner RD
Proc Natl Acad Sci U S A; 2020 Aug; 117(32):19415-19424. PubMed ID: 32719125
[TBL] [Abstract][Full Text] [Related]
9. FEN1 inhibitor increases sensitivity of radiotherapy in cervical cancer cells.
Li JL; Wang JP; Chang H; Deng SM; Du JH; Wang XX; Hu HJ; Li DY; Xu XB; Guo WQ; Song YH; Guo Z; Sun MX; Wu YW; Liu SB
Cancer Med; 2019 Dec; 8(18):7774-7780. PubMed ID: 31670906
[TBL] [Abstract][Full Text] [Related]
10. Letrozole improves the sensitivity of breast cancer cells overexpressing aromatase to cisplatin via down-regulation of FEN1.
Wang Y; Li S; Zhu L; Zou J; Jiang X; Chen M; Chen B
Clin Transl Oncol; 2019 Aug; 21(8):1026-1033. PubMed ID: 30712236
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Flap Endonuclease 1 Correlates with Enhanced Proliferation and Poor Prognosis of Non-Small-Cell Lung Cancer.
Zhang K; Keymeulen S; Nelson R; Tong TR; Yuan YC; Yun X; Liu Z; Lopez J; Raz DJ; Kim JY
Am J Pathol; 2018 Jan; 188(1):242-251. PubMed ID: 29037854
[TBL] [Abstract][Full Text] [Related]
12. Flap endonuclease 1 silencing is associated with increasing the cisplatin sensitivity of SGC‑7901 gastric cancer cells.
Xie C; Wang K; Chen D
Mol Med Rep; 2016 Jan; 13(1):386-92. PubMed ID: 26718738
[TBL] [Abstract][Full Text] [Related]
13. The identification and optimization of 2,4-diketobutyric acids as flap endonuclease 1 inhibitors.
Tumey LN; Huck B; Gleason E; Wang J; Silver D; Brunden K; Boozer S; Rundlett S; Sherf B; Murphy S; Bailey A; Dent T; Leventhal C; Harrington J; Bennani YL
Bioorg Med Chem Lett; 2004 Oct; 14(19):4915-8. PubMed ID: 15341951
[TBL] [Abstract][Full Text] [Related]
14. FEN1 is overexpressed in testis, lung and brain tumors.
Nikolova T; Christmann M; Kaina B
Anticancer Res; 2009 Jul; 29(7):2453-9. PubMed ID: 19596913
[TBL] [Abstract][Full Text] [Related]
15. Complementary non-radioactive assays for investigation of human flap endonuclease 1 activity.
Dorjsuren D; Kim D; Maloney DJ; Wilson DM; Simeonov A
Nucleic Acids Res; 2011 Jan; 39(2):e11. PubMed ID: 21062821
[TBL] [Abstract][Full Text] [Related]
16. Artificial Intelligence, Big Data and Machine Learning Approaches in Precision Medicine & Drug Discovery.
Nayarisseri A; Khandelwal R; Tanwar P; Madhavi M; Sharma D; Thakur G; Speck-Planche A; Singh SK
Curr Drug Targets; 2021; 22(6):631-655. PubMed ID: 33397265
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Myricetin as a Potent Inhibitor of Human Flap Endonuclease 1, Which Potentially Can Be Used as Sensitizing Agent against HT-29 Human Colon Cancer Cells.
Ma L; Cao X; Wang H; Lu K; Wang Y; Tu C; Dai Y; Meng Y; Li Y; Yu P; Man S; Diao A
J Agric Food Chem; 2019 Feb; 67(6):1656-1665. PubMed ID: 30694659
[TBL] [Abstract][Full Text] [Related]
18. YY1 suppresses FEN1 over-expression and drug resistance in breast cancer.
Wang J; Zhou L; Li Z; Zhang T; Liu W; Liu Z; Yuan YC; Su F; Xu L; Wang Y; Zhou X; Xu H; Hua Y; Wang YJ; Zheng L; Teng YE; Shen B
BMC Cancer; 2015 Feb; 15():50. PubMed ID: 25885449
[TBL] [Abstract][Full Text] [Related]
19. FEN1 Inhibition as a Potential Novel Targeted Therapy against Breast Cancer and the Prognostic Relevance of FEN1.
Berfelde J; Hildebrand LS; Kuhlmann L; Fietkau R; Distel LV
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396787
[TBL] [Abstract][Full Text] [Related]
20. Pharmacophore-based screening and identification of novel human ligase I inhibitors with potential anticancer activity.
Krishna S; Singh DK; Meena S; Datta D; Siddiqi MI; Banerjee D
J Chem Inf Model; 2014 Mar; 54(3):781-92. PubMed ID: 24593844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]